THE IMPORTANCE OF RESEARCH
IN THE FIGHT AGAINST TB
With 9.6 million new cases and 1.5 million deaths worldwide in 2014, TB imposes a high burden of human suffering and loss, overwhelmingly borne by poor and vulnerable people living in low and middle income countries.
Over 3 million people who developed TB in 2014 were missed by national systems.
Only a quarter of the 480 000 cases of multidrug-resistant TB (MDR-TB) estimated to have occurred in 2014 were detected and reported.
The MDG objective of reversing incidence of TB by 2015 has been reached, but TB incidence is declining far too slowly, by 1.5% per year.
At this pace, the end of the TB epidemic will not be reached by 2030, given the tools available for TB prevention, care and control are of limited efficacy and are still not readily accessible in some settings.
THE IMPORTANCE OF RESEARCHIN THE FIGHT AGAINST TB With 9.6 million new cases and 1.5 million deaths worldwide in 2014, TB imposes a high burden of human suffering and loss, overwhelmingly borne by poor and vulnerable people living in low and middle income countries. Over 3 million people who developed TB in 2014 were missed by national systems. Only a quarter of the 480 000 cases of multidrug-resistant TB (MDR-TB) estimated to have occurred in 2014 were detected and reported. The MDG objective of reversing incidence of TB by 2015 has been reached, but TB incidence is declining far too slowly, by 1.5% per year. At this pace, the end of the TB epidemic will not be reached by 2030, given the tools available for TB prevention, care and control are of limited efficacy and are still not readily accessible in some settings.
การแปล กรุณารอสักครู่..